Patents by Inventor Baoshan Zhang

Baoshan Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220337095
    Abstract: This application provides a wireless power transmission system. The system includes a transmitter and a receiver, where the transmitter includes a DC/AC inverter circuit, a first resonant inductor, a first capacitor, and a first compensation inductor that are connected in series; and the receiver includes an AC/DC rectifier circuit, a second resonant inductor, a second capacitor, and a second compensation inductor that are connected in series; and power at the transmitter is transmitted to the receiver through electromagnetic induction between the first resonant inductor and the second resonant inductor, and the AC/DC rectifier circuit is configured to provide the rectified power to a load of the receiver. This solution is applicable to a wireless power supply scenario or a wireless charging scenario.
    Type: Application
    Filed: June 29, 2022
    Publication date: October 20, 2022
    Applicant: Huawei Digital Power Technologies Co., Ltd.
    Inventors: Donghao WU, Baoshan WU, Chengliang ZHANG
  • Publication number: 20220337094
    Abstract: A wireless electric energy transmission system is provided, including a transmitter and a receiver. The transmitter includes a DC/AC inverter circuit, a first inductor, and a first capacitor that are connected in series. The transmitter is configured to: detect a value of a resonant frequency of the transmitter; detect a value of a coupling coefficient between the transmitter and the receiver; obtain a value of a constant-voltage operating frequency of the transmitter through calculation based on the resonant frequency and the coupling coefficient; and control an operating frequency of the DC/AC inverter circuit based on the constant-voltage operating frequency obtained through calculation.
    Type: Application
    Filed: June 29, 2022
    Publication date: October 20, 2022
    Applicant: Huawei Digital Power Technologies Co., Ltd.
    Inventors: Baoshan WU, Chengliang ZHANG, Donghao WU, Wei LU
  • Patent number: 11459360
    Abstract: HIV-1 Env ectodomain trimers stabilized in a prefusion mature closed conformation and methods of their use and production are disclosed. In several embodiments, the HIV-1 Env ectodomain trimers and/or nucleic acid molecules can be used to generate an immune response to HIV-1 in a subject. In additional embodiments, the therapeutically effective amount of the HIV-1 Env ectodomain trimers can be administered to a subject in a method of treating or preventing HIV-1 infection.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: October 4, 2022
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Peter Kwong, Marie Pancera, Tongqing Zhou, Ivelin Georgiev, Michael Gordon Joyce, Priyamvada Acharya, Jason Gorman, Yongping Yang, Guillaume Stewart-Jones, Rita Chen, Gwo-Yu Chuang, John Mascola, Baoshan Zhang, Cheng Cheng, Mallika Sastry, Aliaksandr Druz
  • Publication number: 20220306735
    Abstract: The present disclosure relates generally to antibodies and Fc fusion proteins comprising Fc variants, and uses thereof. The Fc variants disclosed herein exhibit elevated affinity towards FcRn at pH 6.0, and/or rapidly disassociate from FcRn at pH 7.
    Type: Application
    Filed: August 27, 2020
    Publication date: September 29, 2022
    Inventors: Brandon DEKOSKY, Peter D. KWONG, Wei JIN, Young Do KWON, Baoshan ZHANG
  • Patent number: 11445746
    Abstract: A robotic arm includes a base, a first robotic arm, a second robotic arm, a robotic hand and a cigarette holder connected in sequence. The cigarette holder includes a cigarette insertion hole and a cigarette smoking tube. The cigarette smoking tube is connected to a smoking simulator. The robotic arm further includes at least one air exhausting hole. The air exhausting hole is located around the cigarette holder and communicated with an air exhauster through an air exhausting pipe. The robotic arm swings to control the cigarette holder to carry a cigarette from a smoking position to an ash flicking position. Airflow is formed near the air exhausting hole by means of air exhaustion, so as to simulate influences of a wind speed in an outdoor environment on the columnar ash in the cigarette smoking process of the human body.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: September 20, 2022
    Assignee: CHINA TOBACCO YUNNAN INDUSTRIAL CO., LTD
    Inventors: Han Zheng, Ying Zhang, Hao Wang, Jianbo Zhan, Zhenhua Yu, Jiao Xie, Xu Wang, Geng Li, Tao Wang, Tingting Yu, Liwei Li, Haiyan Ding, Baoshan Yue, Jiang Yu, Jing Zhang
  • Patent number: 11412776
    Abstract: A smoking path simulation system includes a case, the robotic arm fixedly provided in the case and a cigarette holder mounted at a working end of the robotic arm, and further includes a feeding device, a cigarette tapping device and a cigarette lighting device provided in the case and located at a periphery of the robotic arm, as well as an image acquisition device mounted at the working end of the robotic arm. With the smoking path simulation system, an action path of smoking a cigarette by a consumer may be simulated, and consistency of the simulated action paths may be guaranteed, thus effectively improving precision of test of indexes of a cigarette-combustion performance, such as cigarette-combustion ash integration characteristics, or the like.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: August 16, 2022
    Assignee: CHINA TOBACCO YUNNAN INDUSTRIAL CO., LTD
    Inventors: Han Zheng, Jianbo Zhan, Hao Wang, Zhenhua Yu, Ying Zhang, Geng Li, Tingting Yu, Liang Cheng, Liwei Li, Tao Wang, Xu Wang, Haiyan Ding, Jiao Xie, Baoshan Yue, Jiang Yu
  • Publication number: 20220202066
    Abstract: A robotic arm includes a base, a first robotic arm, a second robotic arm, a robotic hand and a cigarette holder connected in sequence. The cigarette holder includes a cigarette insertion hole and a cigarette smoking tube. The cigarette smoking tube is connected to a smoking simulator. The robotic arm further includes at least one air exhausting hole. The air exhausting hole is located around the cigarette holder and communicated with an air exhauster through an air exhausting pipe. The robotic arm swings to control the cigarette holder to carry a cigarette from a smoking position to an ash flicking position. Airflow is formed near the air exhausting hole by means of air exhaustion, so as to simulate influences of a wind speed in an outdoor environment on the columnar ash in the cigarette smoking process of the human body.
    Type: Application
    Filed: January 21, 2021
    Publication date: June 30, 2022
    Applicant: CHINA TOBACCO YUNNAN INDUSTRIAL CO., LTD
    Inventors: Han ZHENG, Jianbo ZHAN, Hao WANG, Geng LI, Ying ZHANG, Zhenhua YU, Tao WANG, Jiao XIE, Tingting YU, Xu WANG, Liwei LI, Haiyan DING, Baoshan YUE, Jiang YU, Jing ZHANG
  • Publication number: 20220098286
    Abstract: Neutralizing antibodies that specifically bind to HIV-1 Env and antigen binding fragments of these antibodies are disclosed. Nucleic acids encoding these antibodies, vectors and host cells are also provided. Methods for detecting HIV-1 using these antibodies are disclosed. In addition, the use of these antibodies, antigen binding fragment, nucleic acids and vectors to prevent and/or treat an HIV-1 infection is disclosed.
    Type: Application
    Filed: December 14, 2021
    Publication date: March 31, 2022
    Applicants: The United States of America, as represented by the Secretary, Department of Health and Human Servic, The Trustees of Columbia University in the City of New York
    Inventors: Peter Kwong, Young Do Kwon, Ivelin Georgiev, Gilad Ofek, Baoshan Zhang, Krisha McKee, John Mascola, Mark Connors, Gwo-Yu Chuang, Sijy O'Dell, Robert Bailer, Mark Louder, Mangaiarkarasi Asokan, Richard Schwartz, Jonathan Cooper, Kevin Carlton, Michael Bender, Amarendra Pegu, Lawrence Shapiro, Tatyana Gindin, Lisa Kueltzo
  • Publication number: 20220064222
    Abstract: Embodiments of a recombinant Respiratory Syncytial Virus (RSV) F ectodomain trimer stabilized in a prefusion conformation are provided. Also disclosed are nucleic acids encoding the RSV F ectodomain trimer and methods of producing the RSV F ectodomain trimer. Methods for inducing an immune response in a subject are also disclosed. In some embodiments, the method can be a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the recombinant RSV F ectodomain trimer to the subject.
    Type: Application
    Filed: November 11, 2021
    Publication date: March 3, 2022
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Peter Kwong, Barney Graham, John Mascola, Li Ou, Aliaksandr Druz, Man Chen, Wing-Pui Kong, Ivelin Stefanov Georgiev, Emily Rundlet, Michael Gordon Joyce, Yaroslav Tsybovsky, Paul Thomas, Marie Pancera, Mallika Sastry, Cinque Soto, Joseph Van Galen, Guillaume Stewart-Jones, Yongping Yang, Baoshan Zhang, Ulrich Baxa
  • Patent number: 11236152
    Abstract: Neutralizing antibodies that specifically bind to HIV-1 Env and antigen binding fragments of these antibodies are disclosed. Nucleic acids encoding these antibodies, vectors and host cells are also provided. Methods for detecting HIV-1 using these antibodies are disclosed. In addition, the use of these antibodies, antigen binding fragment, nucleic acids and vectors to prevent and/or treat an HIV-1 infection is disclosed.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: February 1, 2022
    Assignees: The United States of America, as represented by the Sectetary, Department of Health and Human Services, The Trustees of Columbia University in the City of New York
    Inventors: Peter Kwong, Young Do Kwon, Ivelin Georgiev, Gilad Ofek, Baoshan Zhang, Krisha McKee, John Mascola, Mark Connors, Gwo-Yu Chuang, Sijy O'Dell, Robert Bailer, Mark Louder, Mangaiarkarasi Asokan, Richard Schwartz, Jonathan Cooper, Kevin Carlton, Michael Bender, Amarendra Pegu, Lawrence Shapiro, Tatyana Gindin, Lisa Kueltzo
  • Publication number: 20220024987
    Abstract: Embodiments of a recombinant human Parainfluenza Virus (hPIV) F ectodomain trimer stabilized in a prefusion conformation are provided. Also disclosed are nucleic acids encoding the hPIV F ectodomain trimer and methods of producing the hPIV F ectodomain trimer. Methods for inducing an immune response in a subject are also disclosed. In some embodiments, the method can be a method for treating or inhibiting a hPIV infection in a subject by administering a effective amount of the recombinant hPIV F ectodomain trimer to the subject.
    Type: Application
    Filed: July 16, 2021
    Publication date: January 27, 2022
    Applicants: The United States of America, as represented by the Secretary, Department of Health and Human, Institute for Research in Biomedicine
    Inventors: Baoshan Zhang, Guillaume Stewart-Jones, John Mascola, Kai Xu, Gwo-Yu Chuang, Li Ou, Peter Kwong, Yaroslav Tsybovsky, Wing-Pui Kong, Aliaksandr Druz, Davide Corti, Antonio Lanzavecchia
  • Publication number: 20220002351
    Abstract: Disclosed are Respiratory Syncytial Virus (RSV) antigens including a recombinant RSV F protein stabilized in a prefusion conformation. Also disclosed are nucleic acids encoding the antigens and methods of producing the antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the antigen to the subject.
    Type: Application
    Filed: September 17, 2021
    Publication date: January 6, 2022
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Peter D. Kwong, Barney S. Graham, Jason S. McLellan, Jeffrey Boyington, Lei Chen, Man Chen, Gwo-Yu Chuang, Ivelin Stefanov Georgiev, Jason Gorman, Michael Gordon Joyce, Masaru Kanekiyo, Gilad Ofek, Marie Pancera, Mallika Sastry, Cinque Soto, Sanjay Srivatsan, Guillaume Stewart-Jones, Yongping Yang, Baoshan Zhang, Tongqing Zhou
  • Publication number: 20210353740
    Abstract: Embodiments of immunogenic conjugates including the HIV-1 Env fusion peptide and methods of their use and production are disclosed. In several embodiments, the immunogenic conjugates can be used to generate an immune response to HIV-1 Env in a subject, for example, to treat or prevent an HIV-1 infection in the subject.
    Type: Application
    Filed: September 23, 2019
    Publication date: November 18, 2021
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Peter Kwong, Li Ou, John Mascola, Baoshan Zhang, Kai Xu, Wing-Pui Kong, Yaroslav Tsybovsky, Cara W. Chao, Jeffrey Boyington, Yiran Wang
  • Patent number: 11174292
    Abstract: Embodiments of a recombinant Respiratory Syncytial Virus (RSV) F ectodomain trimer stabilized in a prefusion conformation are provided. Also disclosed are nucleic acids encoding the RSV F ectodomain trimer and methods of producing the RSV F ectodomain trimer. Methods for inducing an immune response in a subject are also disclosed. In some embodiments, the method can be a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the recombinant RSV F ectodomain trimer to the subject.
    Type: Grant
    Filed: March 29, 2017
    Date of Patent: November 16, 2021
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Peter Kwong, Barney Graham, John Mascola, Li Ou, Aliaksandr Druz, Man Chen, Wing-Pui Kong, Ivelin Stefanov Georgiev, Emily Rundlet, Michael Gordon Joyce, Yaroslav Tsybovsky, Paul Thomas, Marie Pancera, Mallika Sastry, Cinque Soto, Joseph Van Galen, Guillaume Stewart-Jones, Yongping Yang, Baoshan Zhang, Ulrich Baxa
  • Patent number: 11130785
    Abstract: Disclosed are Respiratory Syncytial Virus (RSV) antigens including a recombinant RSV F protein stabilized in a prefusion conformation. Also disclosed are nucleic acids encoding the antigens and methods of producing the antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the antigen to the subject.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: September 28, 2021
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Peter D. Kwong, Barney S. Graham, Jason S. McLellan, Jeffrey Boyington, Lei Chen, Man Chen, Gwo-Yu Chuang, Ivelin Stefanov Georgiev, Jason Gorman, Michael Gordon Joyce, Masaru Kanekiyo, Gilad Ofek, Marie Pancera, Mallika Sastry, Cinque Soto, Sanjay Srivatsan, Guillaume Stewart-Jones, Yongping Yang, Baoshan Zhang, Tongqing Zhou
  • Publication number: 20210283240
    Abstract: Metapneumovirus (MPV) F proteins stabilized in a prefusion conformation, nucleic acid molecules and vectors encoding these proteins, and methods of their use and production are disclosed. In several embodiments, the MPV F proteins and/or nucleic acid molecules can be used to generate an immune response to MPV in a subject. In additional embodiments, the therapeutically effective amount of the MPV F ectodomain trimers and/or nucleic acid molecules can be administered to a subject in a method of treating or preventing MPV infection.
    Type: Application
    Filed: May 28, 2021
    Publication date: September 16, 2021
    Applicants: The United States of America, as represented by the Secretary, Department of Health and Human Servic, Institute for Research in Biomedicine
    Inventors: Peter Kwong, Michael Gordon Joyce, Baoshan Zhang, Yongping Yang, Peter Collins, Ursula Buchholz, Davide Corti, Antonio Lanzavecchia, Guillaume Stewart-Jones
  • Patent number: 11084850
    Abstract: The present invention provides immunogens comprising a recombinant Respiratory Syncytial Virus (RSV) F protein stabilized in a prefusion conformation and nucleic acids encoding such immunogens. In particular the present invention provides polypeptides, polynucleotides, compositions, and uses thereof for eliciting an immune response to bovine respiratory syncytial virus (bRSV). Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the antigen to the subject.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: August 10, 2021
    Assignees: THE PIRBRIGHT INSTITUTE, INSTITUTE FOR RESEARCH IN BIO-MEDICINE, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Lei Chen, Baoshan Zhang, Peter D. Kwong, Davide Corti, Antonio Lanzavecchia, Geraldine Taylor
  • Patent number: 11078239
    Abstract: Embodiments of a recombinant human Parainfluenza Virus (hPIV) F ectodomain trimer stabilized in a prefusion conformation are provided. Also disclosed are nucleic acids encoding the hPIV F ectodomain trimer and methods of producing the hPIV F ectodomain trimer. Methods for inducing an immune response in a subject are also disclosed. In some embodiments, the method can be a method for treating or inhibiting a hPIV infection in a subject by administering a effective amount of the recombinant hPIV F ectodomain trimer to the subject.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: August 3, 2021
    Assignees: The United States of America, as represented by the Secretary, Dept. of Health and Human Services, Institute for Research in Biomedicine
    Inventors: Baoshan Zhang, Guillaume Stewart-Jones, Tongqing Zhou, John Mascola, Kai Xu, Yongping Yang, Paul Thomas, Gwo-Yu Chuang, Li Ou, Peter Kwong, Yaroslav Tsybovsky, Wing-Pui Kong, Aliaksandr Druz, Davide Corti, Antonio Lanzavecchia
  • Patent number: 11027007
    Abstract: Metapneumovirus (MPV) F proteins stabilized in a prefusion conformation, nucleic acid molecules and vectors encoding these proteins, and methods of their use and production are disclosed. In several embodiments, the MPV F proteins and/or nucleic acid molecules can be used to generate an immune response to MPV in a subject. In additional embodiments, the therapeutically effective amount of the MPV F ectodomain trimers and/or nucleic acid molecules can be administered to a subject in a method of treating or preventing MPV infection.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: June 8, 2021
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Institute for Research in Biomedicine
    Inventors: Peter Kwong, Michael Gordon Joyce, Baoshan Zhang, Yongping Yang, Peter Collins, Ursula Buchholz, Davide Corti, Antonio Lanzavecchia, Guillaume Stewart-Jones
  • Patent number: 10858400
    Abstract: Disclosed are immunogens including a recombinant RSV F protein stabilized in a prefusion conformation. Also disclosed are nucleic acids encoding the immunogens and methods of producing the immunogens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the immunogen to the subject.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: December 8, 2020
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Peter Kwong, Barney Graham, Jason McLellan, Man Chen, Baoshan Zhang, Tongqing Zhou, Michael Gordon Joyce, Yongping Yang